Equities

BioLife Solutions Inc

BioLife Solutions Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)26.13
  • Today's Change-0.01 / -0.04%
  • Shares traded355.09k
  • 1 Year change+125.06%
  • Beta1.8976
Data delayed at least 15 minutes, as of Nov 08 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments351970
Total Receivables, Net193423
Total Inventory433528
Prepaid expenses6.776.884.66
Other current assets, total16430.01
Total current assets121138126
Property, plant & equipment, net404847
Goodwill, net225225225
Intangibles, net2132152
Long term investments5.075.074.37
Note receivable - long term------
Other long term assets0.821.610.33
Total assets413450554
LIABILITIES
Accounts payable6.941515
Accrued expenses201611
Notes payable/short-term debt000
Current portion long-term debt/capital leases7.211.971.01
Other current liabilities, total8.521115
Total current liabilities424543
Total long term debt19246.64
Total debt27267.66
Deferred income tax0.190.255.49
Minority interest------
Other liabilities, total131721
Total liabilities758676
SHAREHOLDERS EQUITY
Common stock0.050.040.04
Additional paid-in capital651612585
Retained earnings (accumulated deficit)(313)(247)(107)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total(0.35)(0.68)(0.28)
Total equity338364478
Total liabilities & shareholders' equity413450554
Total common shares outstanding454342
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.